Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
NCT ID: NCT02358083
Last Updated: 2023-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1165 participants
INTERVENTIONAL
2014-08-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Influenza Vaccination in Pregnancy Video Education
NCT02151201
Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric
NCT02907580
Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions
NCT01431183
Flu Shot Pre-visit Questionnaire
NCT05508698
FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging
NCT01467934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1. HPV + Control + Control
HPV is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
No interventions assigned to this group
Arm 2. HPV + Control + Strong
HPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 3. HPV + Control + Disclosure
HPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 4. HPV + Safety + Control
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 5. HPV + Safety + Strong
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 6. HPV + Safety + Disclosure
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 7. Flu + Control + Control
Flu is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
No interventions assigned to this group
Arm 8. Flu + Control + Strong
Flu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 9. Flu + Control + Disclosure
Flu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 10. Flu + Safety + Control
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 11. Flu + Safety + Strong
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Arm 12. Flu + Safety + Disclosure
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Provider Communication about Vaccination
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lives in United States
* Mother or female legal guardian of at least one child aged 9-13
* Able to understand English
* For HPV condition: Target child must not have received any doses of HPV vaccine
* For Flu condition: Target child must not have received the flu vaccine during the prior flu season
Exclusion Criteria
* Not mother or female legal guardian of at least one child ages 9-13
* Not living in United States
* Not able to understand English and Spanish
* For HPV condition: Target child had already received at least 1 dose of the HPV vaccine
* For Flu condition: Target child received the influenza vaccine during the previous flu season
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gregory Zimet
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory D Zimet, PhD
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8645194
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.